Bio-Techne
TECH
#1536
Rank
HK$86.73 B
Marketcap
HK$545.88
Share price
2.06%
Change (1 day)
10.16%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): HK$9.06 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is HK$9.02 Billion. In 2023 the company made a revenue of HK$8.94 Billion an increase over the revenue in the year 2022 that were of HK$8.74 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) HK$9.06 B1.35%
2023 HK$8.94 B2.2%
2022 HK$8.74 B8.99%
2021 HK$8.02 B29.62%
2020 HK$6.19 B6.79%
2019 HK$5.79 B8.64%
2018 HK$5.33 B14%
2017 HK$4.68 B14.35%
2016 HK$4.09 B13.6%
2015 HK$3.60 B13.77%
2014 HK$3.16 B23.77%
2013 HK$2.56 B5.72%
2012 HK$2.42 B1.7%
2011 HK$2.38 B12.22%
2010 HK$2.12 B3.34%
2009 HK$2.05 B-1.04%
2008 HK$2.07 B11.45%
2007 HK$1.86 B13.04%
2006 HK$1.64 B11.07%
2005 HK$1.48 B13.45%
2004 HK$1.30 B9.89%
2003 HK$1.18 B10.68%
2002 HK$1.07 B13.01%
2001 HK$0.95 B12.35%
2000 HK$0.84 B11.35%
1999 HK$0.75 B24.01%
1998 HK$0.61 B24.54%
1997 HK$0.49 B10.26%
1996 HK$0.44 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$329.56 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$20.08 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$154.31 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$155.88 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$15.09 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$423.46 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.24 B-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA